Agfa HealthCare announced that it will launch its new mobile digital radiography (DR) system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting. FreeView technology creates better maneuverability and ease of use by offering a telescoping column for an unobstructed view while driving the mobile DR system.

After comparing more than 20,000 brain scans, researchers have identified differences between traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) despite both conditions sharing common symptoms.

Findings from a study in the July 7 issue of the Journal of the American Medical Association (JAMA) suggest that management approaches for localized, low-risk prostate cancer have improved after years of overtreatment. According to the study, rates of active surveillance/watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with potentially curative local treatment rather than androgen deprivation alone.

Konica Minolta Inc. announced that it has acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer based in Minas Gerais, Brazil, through its Brazilian healthcare sales company, Konica Minolta Healthcare do Brazil.

Planmed introduces a new mammography unit, Planmed Clarity 3D, which utilizes advanced digital breast tomosynthesis (DBT) technology. DBT enables enhanced diagnostics, especially for patients with denser fibroglandular breast tissue.

The first randomized trial investigating the additional value of magnetic resonance imaging (MRI) for screening women with dense breasts, is featured in the current issue of Radiology. The article, “MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50–75 Years with Extremely Dense Breasts: The DENSE Trial Study Design,” presents the rationale and design of the DENSE Trial. Run by Carla van Gils, M.D., and Wouter Veldhuis, M.D., from University Medical Center Utrecht (UMCU) in the Netherlands, the trial seeks to determine the effectiveness of screening with mammography and MRI compared to mammography alone in women who have extremely dense breasts.

mammography, benefits overestimated, Royal Society of Medicine, breast cancer

An in-depth review of randomized trials on screening for various cancers, published in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are likely to have been overestimated. This overestimation results from the use of an unconventional statistical method which differs from that used for other cancer screening trials, concludes the paper co-authored by researchers at King's College London and the University of Strathclyde Institute of Global Public Health at iPRI, France.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now